Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Sychev

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Kardiologiia|April 4, 2013
[Bleeding in the appointment of dabigatran in the patients with renal insufficiency caused by coadministration of spironolactone and ACE inhibitors]D A Andreev, Z K Gappoeva, D A Sychev, et al.
Terapevticheskii Arkhiv|February 1, 2017
[Polypragmasy: A clinical pharmacologist's view]D A Sychev, V A Otdelеnov, N M Krasnova, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Pages from the history of therapeutic schools of the Central Institute for Improvement of Doctors - Russian Medical Academy of Continuous Professional Education]D A Sychev, A M Osadchuk, I D Loranskaya, et al.
Voprosy Pitaniia|November 4, 2005
[Safety of food supplements containing plant components]V G Kukes, V M Bulaev, D A Sychev, et al.
Vestnik Oftalmologii|January 11, 2018
[Role of genetic markers in personalization of anti-angiogenic therapy in patients with exudative age-related macular degeneration]L K Moshetova, D A Sychev, E R Osmanova, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Micro-RNA as a new biomarker of activity of the cytochrome system P-450: significance for predicting the antiplatelet action of P2Y12 receptor inhibitors]E I Rytkin, K B Mirzaev, I V Bure, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|June 30, 2012
[Study on phenotypical activity of isoenzyme CYP3A4 in children]B I Kantemirova, A Kh Chernysheva, A K Starodubtsev, et al.
Vestnik Oftalmologii|June 22, 2017
[Retinal vascular occlusion and polymorphisms in genes coding for components of vitamin K cycle]Sh S Kakhktsyan, L K Moshetova, K I Turkina, et al.
Urologiia (Moscow, Russia : 1999)|January 10, 2023
[Molecular genetic predictors of the efficacy and safety of tamsulosin therapy]S P Abdullaev, M N Shatokhin, O V Teodorovich, et al.
Vestnik Oftalmologii|August 9, 2019
[Pharmacogenetics of timolol]L K Moshetova, M M Soshina, D A Sychev, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Kardiologiia|April 4, 2013
[Bleeding in the appointment of dabigatran in the patients with renal insufficiency caused by coadministration of spironolactone and ACE inhibitors]D A Andreev, Z K Gappoeva, D A Sychev, et al.
Terapevticheskii Arkhiv|February 1, 2017
[Polypragmasy: A clinical pharmacologist's view]D A Sychev, V A Otdelеnov, N M Krasnova, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Pages from the history of therapeutic schools of the Central Institute for Improvement of Doctors - Russian Medical Academy of Continuous Professional Education]D A Sychev, A M Osadchuk, I D Loranskaya, et al.
Voprosy Pitaniia|November 4, 2005
[Safety of food supplements containing plant components]V G Kukes, V M Bulaev, D A Sychev, et al.
Vestnik Oftalmologii|January 11, 2018
[Role of genetic markers in personalization of anti-angiogenic therapy in patients with exudative age-related macular degeneration]L K Moshetova, D A Sychev, E R Osmanova, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Micro-RNA as a new biomarker of activity of the cytochrome system P-450: significance for predicting the antiplatelet action of P2Y12 receptor inhibitors]E I Rytkin, K B Mirzaev, I V Bure, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|June 30, 2012
[Study on phenotypical activity of isoenzyme CYP3A4 in children]B I Kantemirova, A Kh Chernysheva, A K Starodubtsev, et al.
Vestnik Oftalmologii|June 22, 2017
[Retinal vascular occlusion and polymorphisms in genes coding for components of vitamin K cycle]Sh S Kakhktsyan, L K Moshetova, K I Turkina, et al.
Urologiia (Moscow, Russia : 1999)|January 10, 2023
[Molecular genetic predictors of the efficacy and safety of tamsulosin therapy]S P Abdullaev, M N Shatokhin, O V Teodorovich, et al.
Vestnik Oftalmologii|August 9, 2019
[Pharmacogenetics of timolol]L K Moshetova, M M Soshina, D A Sychev, et al.
Pageof 9